Legalization Was Right, Now Regulation Must Catch Up
Why America doesn’t need to abandon cannabis reform, but finally finish it

2026-02-25 · 3 min read

America is finally having an overdue conversation about marijuana. A recent editorial from the NYTimes argues that legalization has gone too far and that the country now faces a growing marijuana problem. As someone who has spent years building a compliant, community-focused cannabis business, I agree with part of that diagnosis , but not the conclusion many will draw from it.
Let’s be clear: legalization was the right decision. Prohibition failed. It fueled mass incarceration, disproportionately harmed Black and Latino communities, and did nothing to reduce demand. Legal cannabis replaced a criminal market with a regulated one and gave adults the freedom to make informed choices.
That said, legalization without thoughtful regulation is incomplete. Cannabis use has increased, and with that growth come real concerns , heavy use, high-THC products, and misleading claims about medical benefits. These are not reasons to roll back legalization. They are signs that the industry and lawmakers must grow up.
At Off The Charts (OTC), we see the difference regulation makes every day. Licensed dispensaries verify age, test products, disclose THC levels, and educate consumers. The most dangerous cannabis products are not found in regulated stores , they exist in the illicit market, where there are no safety standards, no labeling, and no accountability.
Taxation and regulation can play a positive role when done carefully. Reasonable taxes can fund education and research, but excessive taxes risk driving consumers back underground. The goal should be balance: discourage abuse without empowering illegal operators who ignore every rule.
Potency is another area where nuance matters. Cannabis today is stronger than it was decades ago, which makes clear labeling, dosage guidance, and consumer education essential. Panic is not policy. Education is. Adults deserve accurate information so they can consume responsibly.
Where critics are absolutely right is on false medical claims. Cannabis is not a cure-all, and companies that suggest otherwise damage public trust. The industry should welcome stronger enforcement against misleading health claims and support expanded federal research. Truth and transparency are good for consumers , and for the long-term credibility of cannabis.
Some have called for “grudging toleration” of marijuana. I believe we should aim higher: responsible normalization. Treat cannabis like alcohol , legal for adults, restricted for minors, regulated for safety, and discussed honestly.
The real issue isn’t that America legalized cannabis. It’s that we legalized it and then failed to fully regulate, educate, and enforce. That gap can be closed.
Legalization was the first step. Now it’s time to do the hard work that should have followed it.
Source:
NYTimes , It’s Time for America to Admit That It Has a Marijuana Problem
https://www.nytimes.com/2026/02/09/opinion/regulate-legalized-marijuana.html

About Norman Yousif
Founder, Off The Charts
Norman Yousif is the founder of Off The Charts, a licensed cannabis company based in California. He is a vocal advocate for responsible cannabis regulation and has spent years working within the legal framework to promote safe, compliant cannabis use.
Related Articles

Seth Rogen on THC Drinks: 'Someone Is Very Threatened'
In a candid interview, actor and Houseplant founder Seth Rogen weighs in on the push to restrict THC beverages, cannabis culture evolution, and his role in normalizing marijuana use.

Breaking Ground: Cannabis Medicine for Women's Health
Millions of women suffer from endometriosis with limited treatment options. Ananda Pharma is taking a pharmaceutical approach to developing the first regulator-approved CBD treatment for this painful condition.

Missouri Cannabis Sales Reach $1.5 Billion Milestone in 2025
Missouri’s legal cannabis market posted another record year in 2025, generating $1.5 billion in sales and more than $255 million in tax revenue as adult-use marijuana continued to dominate the market.
